Ficoxil Tuggutafla 227 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

ficoxil tuggutafla 227 mg

livisto int'l, s.l. - firocoxibum inn - tuggutafla - 227 mg

Ficoxil Tuggutafla 57 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

ficoxil tuggutafla 57 mg

livisto int'l, s.l. - firocoxibum inn - tuggutafla - 57 mg

Imoxat Evrópusambandið - íslenska - EMA (European Medicines Agency)

imoxat

chanelle pharmaceuticals manufacturing ltd - imidacloprid, moxidectin - antiparasitic products, insecticides and repellents, macrocyclic lactones, milbemycins - cats; dogs; ferrets - for cats suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of ear mite infestation (otodectes cynotis),• the treatment of notoedric mange (notoedres cati),• the treatment of the lungworm eucoleus aerophilus (syn. capillaria aerophila) (adults),• the prevention of lungworm disease (l3/l4 larvae of aelurostrongylus abstrusus),• the treatment of the lungworm aelurostrongylus abstrusus (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara cati and ancylostoma tubaeforme). dýralyfið er hægt að nota sem hluti af meðferðaráætlun fyrir húðsjúkdóm í húðflóa (fad).  for ferrets suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis).  for dogs suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of biting lice (trichodectes canis),• the treatment of ear mite infestation (otodectes cynotis), sarcoptic mange (caused by sarcoptes scabiei var. canis), demodicosis (caused by demodex canis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of circulating microfilariae (dirofilaria immitis),• the treatment of cutaneous dirofilariosis (adult stages of dirofilaria repens)• the prevention of cutaneous dirofilariosis (l3 larvae of dirofilaria repens),• the reduction of circulating microfilariae (dirofilaria repens),• the prevention of angiostrongylosis (l4 larvae and immature adults of angiostrongylus vasorum),• the treatment of angiostrongylus vasorum and crenosoma vulpis,• the prevention of spirocercosis (spirocerca lupi),• the treatment of eucoleus (syn. capillaria) boehmi (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara canis, ancylostoma caninum and uncinaria stenocephala, adults of toxascaris leonina and trichuris vulpis). dýralyfið er hægt að nota sem hluti af meðferðaráætlun fyrir húðsjúkdóm í húðflóa (fad).

Alli (previously Orlistat GSK) Evrópusambandið - íslenska - EMA (European Medicines Agency)

alli (previously orlistat gsk)

glaxosmithkline (ireland) limited - orlistat - offita - Ónæmiskerfi, þó ekki mataræði - alli er ætlað fyrir þyngd tap í fullorðna sem eru of þung (líkami massi, Ætti, stærri 28 kg/m 2) og ætti að taka í tengslum með dálítið hitaeiningaskert, neðri-feitur mataræði.

Xenical Evrópusambandið - íslenska - EMA (European Medicines Agency)

xenical

cheplapharm arzneimittel gmbh - orlistat - offita - Ónæmiskerfi, þó ekki mataræði - xenical er ætlað í tengslum með dálítið hitaeiningaskert fæði í meðferð feitir sjúklinga með líkama massi (Ætti) meiri eða jafnt og 30 kg/m 2, eða offitusjúklinga (Ætti > 28 kg/m 2) með tilheyrandi hættu þáttum. meðferð með orlistat ætti að hætta eftir 12 vikur ef sjúklingarnir hafa verið ekki að missa að minnsta kosti 5% af líkama þyngd eins og mæld í upphafi meðferð.

Ephedrine Sintetica Stungulyf, lausn 50 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

ephedrine sintetica stungulyf, lausn 50 mg/ml

sintetica gmbh - ephedrinum hýdróklóríð - stungulyf, lausn - 50 mg/ml

Ropivacainhydrochlorid Sintetica (Ropivacaine Sintetica 2 mg/ml Stungulyf, lausn) Innrennslislyf, lausn 2 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

ropivacainhydrochlorid sintetica (ropivacaine sintetica 2 mg/ml stungulyf, lausn) innrennslislyf, lausn 2 mg/ml

sintetica gmbh - ropivacainum hýdróklóríð - innrennslislyf, lausn - 2 mg/ml

Ropivacainhydrochlorid Sintetica (Ropivacaine Sintetica 2 mg/ml Stungulyf, lausn) Stungulyf, lausn 2 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

ropivacainhydrochlorid sintetica (ropivacaine sintetica 2 mg/ml stungulyf, lausn) stungulyf, lausn 2 mg/ml

sintetica gmbh - ropivacainum hýdróklóríð - stungulyf, lausn - 2 mg/ml

Ropivacainhydrochlorid Sintetica Stungulyf, lausn 7,5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

ropivacainhydrochlorid sintetica stungulyf, lausn 7,5 mg/ml

sintetica gmbh - ropivacainum hýdróklóríð - stungulyf, lausn - 7,5 mg/ml

Byannli (previously Paliperidone Janssen-Cilag International) Evrópusambandið - íslenska - EMA (European Medicines Agency)

byannli (previously paliperidone janssen-cilag international)

janssen-cilag international n.v.   - paliperidon palmitat - geðklofa - psycholeptics - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.